Jpmorgan Chase & CO 89bio, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in 89bio, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 99,467 shares of ETNB stock, worth $709,199. This represents 0.0% of its overall portfolio holdings.

Number of Shares
99,467
Previous 56,083 77.36%
Holding current value
$709,199
Previous $449,000 63.92%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$7.36 - $9.66 $319,306 - $419,089
43,384 Added 77.36%
99,467 $736,000
Q3 2024

Nov 08, 2024
BUY
$7.36 - $9.66 $319,306 - $419,089
43,384 Added 77.36%
99,467 $736,000
Q2 2024

Dec 26, 2024
SELL
$7.31 - $10.9 $317,137 - $472,885
-43,384 Reduced 43.62%
56,083 $449,000
Q2 2024

Aug 12, 2024
SELL
$7.31 - $10.9 $34,576 - $51,557
-4,730 Reduced 7.78%
56,083 $449,000
Q1 2024

Dec 26, 2024
SELL
$8.13 - $13.77 $314,257 - $532,265
-38,654 Reduced 38.86%
60,813 $707,000
Q1 2024

May 10, 2024
SELL
$8.13 - $13.77 $1.12 Million - $1.9 Million
-138,119 Reduced 69.43%
60,813 $707,000
Q4 2023

Dec 26, 2024
BUY
$6.66 - $16.03 $662,436 - $1.59 Million
99,465 Added 100.0%
198,932 $2.22 Million
Q4 2023

Feb 12, 2024
SELL
$6.66 - $16.03 $348,804 - $839,539
-52,373 Reduced 20.84%
198,932 $2.22 Million
Q3 2023

Nov 14, 2023
BUY
$15.06 - $19.41 $542,928 - $699,749
36,051 Added 16.75%
251,305 $3.88 Million
Q2 2023

Aug 11, 2023
SELL
$14.15 - $22.03 $4.51 Million - $7.02 Million
-318,851 Reduced 59.7%
215,254 $4.08 Million
Q1 2023

May 11, 2023
BUY
$10.48 - $16.94 $4.09 Million - $6.61 Million
390,176 Added 271.09%
534,105 $8.13 Million
Q4 2022

Feb 13, 2023
SELL
$5.52 - $12.73 $440,545 - $1.02 Million
-79,809 Reduced 35.67%
143,929 $1.83 Million
Q3 2022

Nov 14, 2022
BUY
$3.02 - $7.0 $277,830 - $643,979
91,997 Added 69.83%
223,738 $1.3 Million
Q2 2022

Aug 11, 2022
SELL
$2.09 - $4.02 $246,642 - $474,404
-118,011 Reduced 47.25%
131,741 $424,000
Q1 2022

May 11, 2022
BUY
$3.45 - $14.99 $218,316 - $948,567
63,280 Added 33.94%
249,752 $941,000
Q4 2021

Feb 10, 2022
BUY
$11.15 - $19.66 $727,872 - $1.28 Million
65,280 Added 53.86%
186,472 $2.44 Million
Q3 2021

Nov 12, 2021
BUY
$14.91 - $21.31 $1.81 Million - $2.58 Million
121,192 New
121,192 $2.37 Million

Others Institutions Holding ETNB

# of Institutions
163
Shares Held
108M
Call Options Held
73.6K
Put Options Held
1.19M
View Full List

About 89bio, Inc.

ETNB Quotes by TradingView
  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $331M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email